By proceeding, you agree to our Terms of Use and Privacy Policy.
OBiO Technology (Shanghai) Corp., Ltd. ('OBiO', SSE:688238.SH) is a gene and cell therapy-focused biotechnology company founded in 2013.
06-08 December 2022
2021 was a landmark year for clinical readouts within the oncolytic virotherapy field, and now OV developers are poised and ready at the cusp of something remarkable and this promising therapeutic is set to be a critical modality within cancer immuno
Event Ended
USA
Paid
Boston
16-20 May 2023
The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for professionals in gene and cell therapy. The meeting, which we've expanded to four full days in 2023, is the best place for people in the field to learn fr
Hybrid
Los Angeles